Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06628102Not ApplicableRecruiting

Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study

Role: collaborator

NCT04039568Not ApplicableCompleted

Meditation Versus Education for Improving Depression in Chronic Pain, a Randomized Controlled Trial

Role: collaborator

NCT03548558Not ApplicableCompleted

Testing Means to Scale Early Childhood Development Interventions in Rural Kenya

Role: collaborator

NCT04241237Unknown

Concordance Between Liquid and Tissue Biopsy

Role: collaborator

All 4 trials loaded